Journal of Nanobiotechnology | Targeting microglial circMBNL1 opens up a new nanomedicine treatment strategy for major depression
QQ Academic Group: 1092348845

Detailed

This work expands the nucleic acid targets for depression from neurons to microglia and uses peptide-guided nanoparticles for intranasal brain delivery, bypassing the blood-brain barrier. In the futur

Copyright © beijing beike new material Technology Co., Ltd 京ICP备16054715-2号